GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: HOLX
Buy $43

Hologic, Inc. (NASDAQ: HOLX) rated to Buy with price target $43 by Gabelli & Co

Monday,  Oct 26, 2015  9:25 AM ET by Lynn Gilbert

Gabelli & Co rated
Hologic, Inc. (NASDAQ: HOLX) to Buy with price target $43.

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.

Gabelli & Co is a well-known diversified asset manager and financial services company. The company's investment services are primarily offered through its subsidiary GAMCO Asset Management Inc, which manages separate accounts for high net worth individuals, institutions, and qualified pension plans, and through the Company's role as advisor to a family of Mutual Funds. The company's asset management businesses are supported by Gabelli & Company, Inc., an institutional broker/dealer. Gabelli & Company, Inc. distributes the mutual funds managed by Gabelli Funds and publishes investment research which is one of the key elements of GAMCO Investors, Inc.'s success. In addition through its subsidiary Gabelli Securities, Inc., the Company serves as general partner or investment manager in a number of limited partnerships with varying investment objectives.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy